Glutathione

Description

Glutathione (GSH) is a powerful endogenous antioxidant tripeptide that plays a central role in neutralizing free radicals, supporting detoxification (especially in the liver), modulating immune responses, and protecting cells from oxidative stress. Low GSH levels are linked to various conditions involving oxidative damage, inflammation, aging, and chronic diseases.

Scientific evidence for its benefits comes from preclinical studies, observational data, and human clinical trials (including RCTs). However, results vary by form (oral, IV, topical), dose, duration, and population. Many studies are small, short-term, or preliminary, and large-scale, long-term RCTs are limited. Compounded IV glutathione (like the Olympia product you mentioned) is often used off-label in wellness settings, but evidence for IV specifically is weaker and more controversial than for precursors or oral forms.

Well-Supported Benefits (Stronger Evidence)

• Antioxidant and Oxidative Stress Reduction: GSH directly combats reactive oxygen species (ROS). Human studies show oral supplementation (e.g., 250–1,000 mg/day) can increase GSH levels in blood compartments (red blood cells, plasma, lymphocytes) by 30–35% over months, reduce oxidative markers, and enhance natural killer cell activity (immune function). For example, a Penn State study (2013) and others found improved oxidative stress balance and immune markers with liposomal or standard oral forms.

• Liver Health and Detoxification: GSH is crucial for liver detox. Limited pilot studies suggest benefits in non-alcoholic fatty liver disease (NAFLD) or alcohol-related issues, with reductions in liver enzymes (ALT, AST) and oxidative markers. A 2023 review highlights potential in metabolic liver conditions, though more data is needed.

• Specific Conditions:

• In cystic fibrosis and AIDS patients with intestinal GSH deficiency, oral supplementation reduced inflammation, improved nutrient absorption, and supported growth/weight.

• In elderly type 2 diabetes patients (>55 years), long-term oral GSH improved HbA1c and protected against oxidative damage.

• Potential in reducing oxidative stress in autoimmune diseases (e.g., rheumatoid arthritis, lupus) or peripheral artery disease (improved circulation/walking distance in some trials).

• Immune Support: Supplementation (especially higher doses) has boosted natural killer cell cytotoxicity (up to 2–4x in some studies) and lymphocyte function.